ProMIS Neurosciences Inc. (PMN) Stock Analysis

ProMIS Neurosciences Inc. (PMN) is a publicly traded company in the HEALTHCARE sector. It trades at $10.15, carries a market capitalization of $93.35M. This page summarizes the public market data, fundamentals, and frequently asked questions for PMN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $10.15
• Market Cap: $93.35M
• EPS: $-18.60
• 52-Week High: $39.75
• 52-Week Low: $6.27

Market Sentiment

ProMIS Neurosciences Inc. currently has a Bullish sentiment score of 0.30.

About ProMIS Neurosciences Inc.

None

GNG Research Analysis

GNG Research scores ProMIS Neurosciences Inc. (PMN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PMN.

Frequently Asked Questions

Does PMN pay dividends?

ProMIS Neurosciences Inc. (PMN) does not currently pay a regular dividend.

What is PMN's market cap?

ProMIS Neurosciences Inc. (PMN) has a market capitalization of $93.35M with a current stock price of $10.15.